vitamin D3 analogs (Johns Hopkins/Parke-Davis)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namevitamin D3 analogs (Johns Hopkins/Parke-Davis)
Drug Alias NameMCW-ACYBMCW-YBJK-1624502MCW-005Y-B
ClassificationSmall molecules
Mechanisms of ActionVitamin D analoguesVitamin D receptor agonists
TargetsVitamin D receptor
Therapy Area/IndicationsMelanomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParke-Davis CorpJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsMelanomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A